Oral Oncology
Volume 37, Issue 1 , Pages 42-49 , January 2001

Assessment of various topical oral formulations by bone marrow transplant recipients

  • L.A. Bellm

      Affiliations

    • IntraBiotics Pharmaceuticals Inc., Mountain View, CA 94043, USA
    • ,
  • J.B. Epstein

      Affiliations

    • British Columbia Cancer Agency, Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, Canada
    • University of Washington, Seattle, WA, USA
    • ,
  • A.M. Rose-Ped

      Affiliations

    • Empirica Inc., Portland, OR, USA
    • ,
  • R. Fu

      Affiliations

    • IntraBiotics Pharmaceuticals Inc., Mountain View, CA 94043, USA
    • ,
  • P.J. Martin

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    • ,
  • H.J. Fuchs

      Affiliations

    • IntraBiotics Pharmaceuticals Inc., Mountain View, CA 94043, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-650-526-6800; fax: +1-650-969-0663

Received 26 April 2000 ,Accepted 4 May 2000.

References 

  1. Eisen D, Essell J, Broun ER. Oral cavity complications of bone marrow transplantation. Seminars in Cutaneous Medicine and Surgery. 1997;16:265–272
  2. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Supp Care Cancer. 2000;8:33–39
  3. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholesytramine in the treatment of hypercholesterolemia in children (a randomized, crossover trial). The Journal of Pediatrics. 1997;130:266–273
  4. Brun J. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate (a comparative study). The Journal of International Medical Research. 1994;22:266–272
  5. Cloyd JC, Kriel RL, Jones-Saete CM, Ong BY, Janik JT, Remmel RP. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and oral preference. The Journal of Pediatrics. 1992;120:634–638
  6. Epstein JB, Stevenson-Moore P. A clinical comparative trial of saliva substitutes on radiation induced salivary gland hypofunction. Special Care in Dentistry. 1992;12:21–23
  7. Epstein JB. Antifungal therapy in oropharyngeal mycotic infections. Oral Surgery, Oral Medicine, Oral Pathology. 1990;69:32–34
  8. Epstein JB, Polsky B. Oropharyngeal candidiasis (A review of its clinical spectrum and current therapies). Clinical Therapeutics. 1998;20:40–57

PII: S1368-8375(00)00054-3

Oral Oncology
Volume 37, Issue 1 , Pages 42-49 , January 2001

Article Tools

* Image Usage & Resolution